Log in to search using one of your social media accounts:

 

Plendil (Felodipine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2017 Category: Drugs & Pharmacology Source Type: news

AstraZeneca signs deal to sell commercial rights for Seloken in Europe
AstraZeneca has entered an agreement to provide the commercial rights for Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax fixed-dose combination (metoprolol succinate and felodipine) treatments i … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 22, 2017 Category: Pharmaceuticals Source Type: news

AstraZeneca enters agreement with Recordati for Seloken in Europe
AstraZeneca announced today that it has entered into an agreement with Recordati S.p.A (Recordati) for the commercial rights to Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax fixed-dose combination (metoprolol succinate and felodipine) treatments in Europe. (Source: World Pharma News)
Source: World Pharma News - May 22, 2017 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

felodipine (Plendil)
Title: felodipine (Plendil)Category: MedicationsCreated: 4/3/1999 12:00:00 AMLast Editorial Review: 7/8/2016 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - July 8, 2016 Category: Cardiology Source Type: news

AstraZeneca enters licensing agreement with China Medical System Holdings for hypertension medicine
AstraZeneca today announced it has entered into a licensing agreement with China Medical System Holdings Ltd (CMS) for the commercialisation rights in China to its calcium channel blocker, Plendil (felodipine). Plendil was first approved in China in 1995 for the treatment of hypertension or high blood pressure and in 2015 achieved Product Sales of $189 million. (Source: World Pharma News)
Source: World Pharma News - February 29, 2016 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Orchid Chemicals gets USFDA nod for two generic drugs
The nod was for generic Rivastigmine capsules and Felodipine extended release tablets aimed at treating mild to moderate dementia and hypertension, respectively. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 12, 2015 Category: Pharmaceuticals Source Type: news